Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EVRAZ PLC M&A Activity 2018

Dec 27, 2018

5304_rns_2018-12-27_d0dbfe07-e0a2-4a7c-aa05-c340eff5f012.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4852L

Evraz Plc

27 December 2018

Response to Press Speculation

EVRAZ plc (the "Company" and together with its subsidiaries the "Group") notes recent press speculation regarding potential combination of the Group's and Sibuglemet Holding's coal assets, or "Sibuglemet".

The Company has previously entered into a new arms-length management contract around Sibuglemet assets and further to the announcement made on 29 May 2018, which was published on the Company's website, confirms its strategic interest to explore possible options in relation to the coal assets of Sibuglemet with an aim of increasing the long-term security of supply of a wide range of coking coal grades required for Group's operations.

The Company notes however that such options have not been considered by the Company's Board of Directors as at this point and accordingly no decisions have been made. The Company will make further announcements in due course as and if may be appropriate.

For further information:

Media Relations:

London: +44 207 832 8998                             Moscow: +7 495 937 6871

[email protected]

Investor Relations:

London: +44 207 832 8990                            Moscow: +7 495 232 1370

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCEAXAKALLPFEF